NR 565 / NR565 Advanced Pharmacology Fundamentals Week 5 Study Guide | Chapters 26 and 47 | 20202/2021| Complete Guide |Chamberlain College
Chapter 26: Drugs used in treating eye & ear disorders
Contraindications f
...
NR 565 / NR565 Advanced Pharmacology Fundamentals Week 5 Study Guide | Chapters 26 and 47 | 20202/2021| Complete Guide |Chamberlain College
Chapter 26: Drugs used in treating eye & ear disorders
Contraindications for topical beta blockers Beta blockers
• Suppress conduction through the atrioventricular (AV) node; therefore, topical beta blockers are contraindicated in patients with bradycardia or advanced AV block.
• Do not use in patients with compromised ventricular dysfunction, cardiogenic shock, or with systolic congestive HF
• D/c at first sign of cardiac failure
• Contraindicated with hypotension
• Use with caution: poorly controlled DM and hyperthyroidism
• Surgical patients should be monitored closely for cardiac failure
o Withdraw before surgery 2 days prior
• Contraindicated with Raynaud’s disease or PVD, CVD
• Preg cat C: fetal anomalies and fetotoxicity in animal studies
Prophylaxis for opthalmia neonatorum
• Common patient group: infants younger than 1 month who presents with conjunctivitis should have Gram's stain, antigen detection tests, and cultures of the eye discharge to rule out gonococcal, chlamydial, or HSV origin.
• Chlamydia is the most common cause of neonatal conjunctivitis
• Gonococcal conjunctivitis is the most serious cause of ophthalmia neonatorum owing to concerns about the bacteria causing blindness
• Prophylaxis: Administration of antibiotic eye medication within 1 hour of delivery
• Erythromycin ointment 0.5% (0.25 to 0.5-inch ribbon in each eye)
• Chlamydial conjunctivitis is not prevented by prophylactic use of erythromycin at birth therefore any mucopurulent eye discharge in the first few weeks of life should be evaluated for chlamydia.
Glaucoma: Treatment, dosing, and patient education:
• IOP damages the optic nerve
• Leading cause of blindness worldwide
• 6-8 times more likely in African Americans than Caucations
• Antiglaucoma medications are prescribed by ophthalmologists. Dosage is determined by the clinical condition of the patient.
Treatment and dosing
• Current medical therapies are aimed at
o decreasing the production of aqueous humor at the ciliary body and
o Increasing the outflow of this fluid from the angle structures
• Requires evaluation and treatment by an ophthalmologist
o FNPs need to be aware of the medications prescribed, drug interactions, and ADRs
• Antiglaucoma agents are prescribed by ophthalmologists and dosage is determined by the clinical condition of the patient
• Four categories: Beta Blockers, adrenergic agonists, miotics, and carbonic anhydrase (CA) inhibitors
o Beta Blockers:
Betaxolol, carteolol, metipranolol, levobunolol, timolol
o Adrenergic Agonists
Apraclonidine, brimonidine
o Miotics
Carbachol, pilocarpine, echothiophate
o Carbonic Anhydrase Inhibitors
Acetazoleamide, brinzolamide, dorzolamide, methazolamide
Patient education
• The patient should be instructed to administer the medication exactly as the ophthalmologist has prescribed
• Abruptly stopping the medication can increase adverse effects.
• The patient should have been instructed by the ophthalmologist regarding the adverse effects of the medication.
o Reinforcement may be necessary. If the patient is experiencing adverse effects from the medication, the primary care provider can facilitate a referral back to the ophthalmologist.
Allergic or Vernal conjunctivitis: Treatment, dosing, and patient education
• Occurs in response to a variety of allergens
• Vernal conjunctivitis refers to conjunctivitis that occurs primarily in the spring, usually because of an allergen.
• The mast cell stabilizers (lodoxamide, cromolyn sodium) may be used to treat vernal conjunctivitis and may be used safely for up to 3 months.
Treatment and Dosing
• Ketotifen (H1 blocker) for allergic conjunctivitis and ocular pruritus.
o The dose used in adults and children over age 3 is 1 drop in the affected eye every 8 to 12 hours
• Levocabastine (H1 blocker): allergic conjunctivitis and ocular pruritis
o 1 drop in the affected eye 4 times a day.
• Mast Cell Stabilizers:
o Cromolyn sodium (1-2 gtt, 4-6 times/day)
[Show More]